Trials / Unknown
UnknownNCT02883725
National Register of Oesophageal Atresia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The esophageal atresia is a group of birth defects including a break in continuity of the esophagus with or without persistent communication with the trachea (tracheoesophageal fistula), sometimes associated (from 50%) of other malformations (heart, kidney, digestive ...). The current prognosis for this ailment is good. However he persists a mortality (\<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) . The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France. The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | data collection |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2016-08-30
- Last updated
- 2022-05-18
Locations
37 sites across 3 countries: France, Guadeloupe, Martinique
Source: ClinicalTrials.gov record NCT02883725. Inclusion in this directory is not an endorsement.